SCHEMBL6765010

SCHEMBL6765010

COc1ccc(NC(=O)Nc2cccc(C(C)=O)c2)c(O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
MAPT P10636 4/20 0.60
PKM P14618 2/20 0.60
ALDH1A1 P00352 5/20 0.60
RAB9A P51151 4/20 0.60
NPC1 O15118 3/20 0.60
MITF O75030 1/20 0.60
LMNA P02545 2/20 0.58
POLB P06746 1/20 0.57
GFER P55789 1/20 0.57
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
TSHR P16473 2/20 0.57
TP53 P04637 1/20 0.57
MAPK1 P28482 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
TRPV1 Q8NER1 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6767742 0.91 MAPT (0.64) MEN1KMT2AMAPTPKMALDH1A1
SCHEMBL6763008 0.85 CXCR2 (0.67) MEN1KMT2AMAPTPKMALDH1A1
SCHEMBL6763521 0.85 FADS1 (0.64) MEN1KMT2AMAPTPKMALDH1A1
SCHEMBL6763526 0.85 MAPT (0.77) MEN1KMT2AMAPTPKMALDH1A1
SCHEMBL6760893 0.85 ALDH1A1 (0.60) MEN1KMT2AMAPTPKMALDH1A1
SCHEMBL6760907 0.85 DDX3X (0.59) MEN1KMT2AMAPTPKMALDH1A1
SCHEMBL4356025 0.84 TRPV1 (0.70) MEN1KMT2AMAPTPKMALDH1A1
SCHEMBL1463349 0.81 GSK3A (0.66) MEN1KMT2AMAPTALDH1A1RAB9A
SCHEMBL6764102 0.81 CXCR1 (0.62) MEN1KMT2AMAPTPKMALDH1A1
SCHEMBL6763519 0.81 MEN1 (0.70) MEN1KMT2AMAPTPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063742-A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity NEUROSEARCH A/S (DK) 2004-04-01 US claimed
US-20040063742-A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity NEUROSEARCH A/S (DK) 2004-04-01 US disclosed